Analytical Data
-
基因名
CTSS
- Application
-
别名
CTS-S
-
种属
Mouse
-
表达系统
E. coli
-
标签
N-His
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
O70370
-
表达区间
Leu123~Glu339
-
分子量
33kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
CTSS (Cathepsin S) is a cysteine protease that plays a significant role in various physiological and pathological processes, including immune response, inflammation, and cancer progression. As a member of the cathepsin family, CTSS is predominantly expressed in antigen-presenting cells and is crucial for the processing of major histocompatibility complex (MHC) class II molecules, thus influencing T-cell activation. Research has shown that aberrant CTSS activity is linked to several diseases, including autoimmune disorders and tumors, making it a potential therapeutic target. The recombinant production of CTSS has enabled scientists to study its function and to explore its role in disease mechanisms in more detail. By generating CTSS in a controlled laboratory setting, researchers can investigate its enzymatic properties, interactions with substrates, and regulatory mechanisms. Additionally, the availability of recombinant CTSS facilitates the development of inhibitors that could be useful in clinical settings, including cancer therapeutics and immunomodulation. The ongoing studies aim not only to clarify CTSS's biological functions but also to harness its potential in designing novel treatment strategies targeting various disease pathways.
